Clinically Suspected Myocarditis (ESC 2013 Criteria)
Identifies suspected myocarditis using ESC 2013 diagnostic criteria. Guides CMR, endomyocardial biopsy, and activity restriction.
Score interpretation
ESC 2013 criteria for clinically suspected myocarditis are not met.
→ Consider alternative diagnoses; reassess if new findings.
Criteria met, provided coronary disease, known heart disease and extracardiac causes are excluded. Endomyocardial biopsy confirms the diagnosis; CMR supports it.
→ Admit and monitor; coronary angiography or CT coronary angiography to exclude coronary disease; CMR; consider endomyocardial biopsy if fulminant or unexplained; avoid competitive sport for 3–6 months.
Interpretation bands for the Myocarditis Assessment. Apply clinical judgement and local guidance.
References
- Caforio ALP et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-2648.
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.
